Purdue Pharma and its Sackler family owners have reached a new opioid settlement to resolve thousands of lawsuits.

AG Campbell secures a $7.4 billion opioid settlement against Purdue Pharma and the Sackler family for Massachusetts.

Attorney General James Releases Joint Statement with 10 State Attorneys General in regards of Federal immigration enforcement ...

On Jan. 24, 2011, a suicide bomb attack at Moscow's Domodedovo airport international arrival gate killed 37 people and ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

Purdue Pharma, under the leadership of the Sackler family, manufactured and sold opioids like Oxycontin for decades.

The new settlement reopens a path to ending Purdue’s chapter 11 case, the longest and costliest corporate bankruptcy stemming from the U.S. opioid epidemic.

The settlement, in principle, would not shield Purdue Pharma or the Sackler family from additional liability over their role in the opioid crisis.

The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.

Pennsylvania expects to receive $212 million over 15 years as part of a multi-state settlement with the Sackler family.

Several US states have reached a $7.4 billion settlement with the Sackler family and their pharmaceutical company Purdue over the opioid crisis that has ravaged the lives of millions of Americans, ...